Our SVM classification model showed that the episignature was highly specific and sensitive, and confirmed that TRIP12 biomarkers could be differentiated from other EpiSignTM disorders associated with developmental delay and intellectual disability. This evidence concerns the gene TRIP12 and Intellectual disability.